Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis

Clinical and Experimental Allergy

Volumn 26, Issue 7, 1996, Pages 766-774

  Saetta, M ^a   Di Stefano, A ^a   Maestrelli, P ^a   Turato, G ^a   Mapp, C E ^a   Pieno, M ^a   Zanguochi, G ^b   Del Prete, G ^c   Fabbri, L M ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

biopsies; immunohistochemistry; inflammation

Indexed keywords

INTERLEUKIN 5;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CHRONIC BRONCHITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; FEMALE; FIBEROPTIC BRONCHOSCOPY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0029837863     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00606.x     Document Type: Article

References (37)

1. Djukanovic R, Wilson JW, Britten KM et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142: 863-71.
2. Bentley AM, Menz G, Storz CHR et al. Identification of T-lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Am Rev Respir Dis 1992; 146: 500-6.
3. Saetta M, Di Stefano A, Maestrelli P et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1992; 145: 160-8.
4. Lacoste JY, Bousquet J, Chanez P et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993; 92: 537-48.
5. Saetta M, Di Stefano A, Maestrelli P et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994; 150: 1646-52.
6. Clutterbuck EJ, Hirst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood 1988; 73: 1504-13.
7. Lopez AF, Sanderson CJ, Gamble JR et al. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988; 167: 219-24.
8. Walsh GM, Hartnell A, Wardlaw AJ et al. IL-5 enhances the in vitro adhesion of human eosinophils but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990; 71: 258-65.
9. Yamaguchi Y, Hayashi Y, Sugama Y et al. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J Exp Med 1988; 167: 1737-42.
10. Bradding P, Roberst JA, Britten KM et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10: 471-80.
11. Azzawi M, Bradley B, Jeffery K et al. Identification of activated T-lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407-13.
12. Bentley AM, Maestrelli P, Saetta M et al. Activated-T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol 1992; 89: 821-9.
13. Saetta M, Di Stefano A, Maestrelli P et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147: 301-6.
14. Walker C, Virkow JC, Bruijnzeel, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991; 146: 1829-35.
15. Walker C, Bode E, Boer L et al. Allergic and nonallergic asthmatics have distinct patterns of T-Cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis. 1992; 146:109-15.
16. Robinson DS, Hamid Q, Ying S et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
17. Hamid Q, Azzawi M, Ying S et al. Expression of mRNA interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87: 1541-6.
18. Bentley AM, Meng Q, Robinson DS et al. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen-inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993; 8: 35-42.
19. Sheffer AL. International consensus report on diagnosis and treatment of asthma. Eur Respir J 1992; 5: 601-41.
20. Medical Section of the American Lung Association. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225- 43.
21. CECA. Aide-memoire of spirographic practice for examining ventilatory function. 2nd edn. Luxemburg: Industrial Health and Medicine, 1971.
22. Mapp CE, Polato R, Maestrelli P, Hendrich DJ, Fabbri LM. Time course of the increase in airway responsiveness associated with late asthmatic reactions to toluene diisocyanate in sensitized subjects. J Allergy Clin Immunol 1985; 75: 568-72.
23. Saetta M, Maestrelli P, Turato G et al. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med 1995; 151:489-94.
24. Del Prete GF, De Carli M, D'Elios MM et al. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993; 23: 1445-9
25. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-10.
26. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993; 147: 697-704.
27. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-9.
28. Dunnil MS, Massarella GR, Anderson JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 1969; 24: 176-9.
29. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK. T Lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis 1992; 145: 1477-82
30. Sanchez-Borges M, Orozeo A, Di Biagio E, Tami I, Suarez-Chacon R. Eosinophilia in early stage human immunodeficiency virus infection. J Allergy Clin Immunol 1993; 92: 494-5.
31. Tomassini JE, Graham D, DeWitt CM et al. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1989; 86: 4907-11.
32. Di Stefano A, Maestrelli P, Roggeri A et al. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 1994; 149: 803-10.
33. Vignola AM, Campbell AM, Chanez P et al. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 1993; 148: 689-94.
34. Owen WF. Cytokine regulation of eosinophil-mediated inflammatory reactions by modulation of 5-Lipoxygenase pathway activity. In: Holgate ST, Austen KF, Lichtenstein LM, Kay AB, eds. Asthma, Physiology, Immunopharmacology, and Treatment. Fourth International Symposium, Academic Press, 1993: 109-14.
35. Wallen N, Kita H, Weiler D, Gleich GE. Glucocorticoids inhibit cytokine-mediated eosinophils survival. J Immunol 1991; 147: 3490-5.
36. Wardlaw J, Moqbel R, Cromwell O, Kay AB. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986; 78: 1701-6.
37. Alam R, Stafford S, Forsythe PA. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993; 150: 3442-6.